Donepezil dose-dependently inhibits acetylcholinesterase activity in various areas and in the presynaptic cholinergic and the postsynaptic cholinoceptive enzyme-positive structures in the human and rat brain.
In the symptomatic treatment of mild to moderately severe dementia associated with Alzheimer's disease, donepezil (E2020) has been introduced for the inhibition of acetylcholinesterase activity in the human brain. However, there is no morphological evidence as to how this chemical agent affects the acetylcholinesterase-positive structures in the various areas of the human and the rat CNS. This study demonstrates by histochemical means that donepezil exerts a dose-dependent inhibitory effect in vitro on acetylcholinesterase activity. The most sensitive areas were the cortex and the hippocampal formation. Within the different layers of the cortex, the cholinoceptive acetylcholinesterase-positive postsynaptic pyramidal cell bodies were more sensitive than the presynaptic cholinergic axonal processes. In the cortex, the cell body staining was already abolished by even 2 x 10(-8)M donepezil, whereas the axonal staining could be eliminated only by at least 5 x 10(-8)M donepezil. In the hippocampus, the axonal acetylcholinesterase reaction end-product was eliminated by 5 x 10(-7)M donepezil. The most resistant region was the putamen, where the staining intensity was moderately reduced by 1 x 10(-6)M donepezil. In the rat brain, the postsynaptic cholinoceptive and presynaptic cholinergic structures were inhibited by nearly the same dose of donepezil as in the human brain. These histochemical results provide the first morphological evidence that, under in vitro circumstances, donepezil is not a general acetylcholinesterase inhibitor in the CNS, but rather selectively affects the different brain areas and, within these, the cholinoceptive and cholinergic structures. The acetylcholinesterase staining in the nerve fibers (innervating the intracerebral blood vessels of the human brain and the extracerebral blood vessels of the rat brain) and at the neuromuscular junction in the diaphragm and gastrocnemius muscle of rat, was also inhibited dose dependently by donepezil. It is concluded that donepezil may be a valuable tool with which to influence both the pre- and the postsynaptic acetylcholinesterase-positive structures in the human and rat central and peripheral nervous systems.
Kasa
P
P
Alzheimer's Disease Research Centre, University of Szeged, H-6720 Szeged, Hungary. kp@comser.szote.u-szeged.hu
Papp
H
H
Kasa
P
P
Torok
I
I
D000110:Acetylcholinesterase / Q000187:drug effects* / Q000378:metabolism; D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D000818:Animals; D020532:Basal Nucleus of Meynert / Q000166:cytology / Q000187:drug effects / Q000201:enzymology; D001808:Blood Vessels / Q000166:cytology / Q000201:enzymology / Q000294:innervation; D001921:Brain / Q000166:cytology / Q000187:drug effects* / Q000201:enzymology; D002540:Cerebral Cortex / Q000166:cytology / Q000187:drug effects / Q000201:enzymology; D002799:Cholinergic Fibers / Q000187:drug effects* / Q000201:enzymology / Q000648:ultrastructure; D003712:Dendrites / Q000187:drug effects* / Q000201:enzymology / Q000648:ultrastructure; D000077265:Donepezil; D004305:Dose-Response Relationship, Drug; D006624:Hippocampus / Q000166:cytology / Q000187:drug effects / Q000201:enzymology; D006801:Humans; D007189:Indans / Q000494:pharmacology*; D008875:Middle Aged; D017072:Neostriatum / Q000166:cytology / Q000187:drug effects / Q000201:enzymology; D009469:Neuromuscular Junction / Q000187:drug effects / Q000378:metabolism; D010880:Piperidines / Q000494:pharmacology*; D017966:Pyramidal Cells / Q000166:cytology / Q000187:drug effects* / Q000201:enzymology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013569:Synapses / Q000187:drug effects* / Q000201:enzymology / Q000648:ultrastructure
D007189:Indans; D010880:Piperidines; D000077265:Donepezil; D000110:Acetylcholinesterase